摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(5-trifluoromethyl-2-pyridinyl)ethanesulfonamide | 141284-82-4

中文名称
——
中文别名
——
英文名称
N-(5-trifluoromethyl-2-pyridinyl)ethanesulfonamide
英文别名
N-(5-trifluoromethyl-2-pyridyl)ethanesulfonamide;N-[5-(trifluoromethyl)pyridin-2-yl]ethanesulfonamide
N-(5-trifluoromethyl-2-pyridinyl)ethanesulfonamide化学式
CAS
141284-82-4
化学式
C8H9F3N2O2S
mdl
——
分子量
254.233
InChiKey
BJVOLYZUDVJXFE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    67.4
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of N-(Trifluoromethyl-2-pyridinyl)arenesulfonamides as an Inhibitor of Secretory Phospholipase A2
    作者:Hitoshi Nakayama、Yuka Morita、Hirohiko Kimura、Keiichi Ishihara、Satoshi Akiba、Jun'ichi Uenishi
    DOI:10.1248/cpb.59.783
    日期:——
    A series of N-(trifluoromethyl-2-pyridinyl)alkane- and arenesulfonamides 2—5 have been synthesized by the substitution reaction of 2-chloro(trifluoromethyl)pyridines 6 with alkane- and arenesulfonamides 7. Their inhibitory activities against secretory phospholipase A2 of porcine pancreas were examined and the analog N-[4,5-bis(trifluoromethyl)-2-pyridinyl]-4-trifluoromethylbenzenesulfonamide 4i was shown to have the highest inhibitory activity, with an IC50 value of 0.58 mM.
    一系列N-(三氟甲基-2-吡啶基)烷基和芳基磺酰胺2—5通过2-氯(三氟甲基)吡啶6与烷基和芳基磺酰胺7的取代反应合成。测定了它们对猪胰腺分泌磷脂酶A2的抑制活性,发现类似物N-[4,5-双(三氟甲基)-2-吡啶基]-4-三氟甲基苯磺酰胺4i具有最高的抑制活性,IC50值为0.58 mM
  • Diaminotrifluoromethylpyridine derivatives and phospholipase A.sub.2
    申请人:Ishihara Sangyo Kaisha Ltd.
    公开号:US05229403A1
    公开(公告)日:1993-07-20
    A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1 (W.sup.2 W.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R.sup.2 and R.sup.7, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R.sup.3, R.sup.8 and R.sup.10, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R.sup.4, R.sup.5, R.sup.11 and R.sup.12, which are independent from one another, is alkyl which may be substituted, each of W.sup.1, W.sup.2, W.sup.3 and W.sup.4, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is --COCF.sub.2 X.sup.1 wherein X.sup.1 is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is --COCF.sub.2 X.sup.2 wherein X.sub.2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or --COOX.sup.3 wherein X.sup.3 is alkyl which may be substituted or phenyl which may be substituted, is excluded.
    化合物的名称为一种二氟甲基吡啶二胺衍生物的盐,其化学式为(I):##STR1## 其中X为--CW.sup.1 R.sup.1,--COCOR.sup.2,--CW.sup.1 NHCOR.sup.2,--C(.dbd.W.sup.1(W.sup.2W.sup.3或--CW.sup.1 N(R.sup.4)R.sup.5,Y为烷基,--CW.sup.3 R.sup.6,--COCOR.sup.7,--NHCOR.sup.7,--C(.dbd.W.sup.3)W.sup.4 R.sup.8,--(NH).sub.m SO.sub.2 R.sup.9,--(NH).sub.m SO.sub.2 OR.sup.10或--(NH).sub.m SO.sub.2 NR.sup.11)R.sup.12,其中每个独立的R.sup.1,R.sup.6和R.sup.9是链烃基,可以被取代的单环烃基,可以被取代的多环烃基,可以被取代的单环杂环基或可以被取代的多环杂环基,每个独立的R.sup.2和R.sup.7是可以被取代的烷基,可以被取代的烷氧基,可以被取代的苯基或可以被取代的苯氧基,每个独立的R.sup.3,R.sup.8和R.sup.10是可以被取代的烷基,可以被取代的烯基,可以被取代的炔基,可以被取代的环烷基,可以被取代的苯基或可以被取代的苄基,每个独立的R.sup.4,R.sup.5,R.sup.11和R.sup.12是可以被取代的烷基,每个独立的W.sup.1,W.sup.2,W.sup.3和W.sup.4是氧原子或硫原子,m为0或1,但其中X和Y之一为--COCF.sub.2X.sup.1,其中X.sup.1为氢原子,卤原子,烷基或卤代烷基,另一个为--COCF.sub.2X.sup.2,其中X.sub.2为氢原子,卤原子,烷基,卤代烷基或烷基羰基,或--COOX.sup.3,其中X.sup.3是可以被取代的烷基或可以被取代的苯基。
  • Diaminotrifluoromethylpyridine derivatives, process for their production
    申请人:Ishihara Sangyo Kaisha Ltd.
    公开号:US05492908A1
    公开(公告)日:1996-02-20
    A method of treating rheumatoid arthritis using a diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted as further defined herein.
    使用公式(I)或其盐的二氨基三氟甲基吡啶衍生物治疗类风湿性关节炎的方法: 其中X为--CW1R1,--COCOR2,--CW1NHCOR2,--C(.dbd.W1)W2R3或--CW1N(R4)R5,Y为烷基,--CW3R6,--COCOR7,--NHCOR7,--C(.dbd.W3)W4R8,--(NH)mSO2R9,--(NH)mSO2OR10或--(NH)mSO2N(R11)R12,其中R1,R6和R9分别是独立的链烃基,可以被取代的单环烃基,可以被取代的多环烃基,可以被取代的单环杂环基或可以被取代的多环杂环基,如此处进一步定义。
  • Diaminotrifluoromethylpyridine compounds and phospholipase A.sub.2
    申请人:Ishihara Sangyo Kaisha Ltd.
    公开号:US05260320A1
    公开(公告)日:1993-11-09
    A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R.sup.2 and R.sup.7, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R.sup.3, R.sup.8 and R.sup.10, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R.sup.4, R.sup.5, R.sup.11 and R.sup.12, which are independent from one another, is alkyl which may be substituted, each of W.sup.1, W.sup.2, W.sup.3 and W.sup.4, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is --COCF.sub.2 X.sup.1 wherein X.sup.1 is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is --COCF.sub.2 X.sup.2 wherein X.sup.2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or --COOX.sup.3 wherein X.sup.3 is alkyl which may be substituted or phenyl which may be substituted, is excluded.
    一种公式(I)或其盐的二氨基三氟甲基吡啶衍生物:##STR1## 其中X是--CW.sup.1 R.sup.1,--COCOR.sup.2,--CW.sup.1 NHCOR.sup.2,--C(.dbd.W.sup.1)W.sup.2 R.sup.3或--CW.sup.1 N(R.sup.4)R.sup.5,而Y是烷基,--CW.sup.3 R.sup.6,--COCOR.sup.7,--NHCOR.sup.7,--C(.dbd.W.sup.3)W.sup.4 R.sup.8,--(NH).sub.m SO.sub.2 R.sup.9,--(NH).sub.m SO.sub.2 OR.sup.10或--(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12,其中R.sup.1,R.sup.6和R.sup.9互相独立,分别是链烃基,可取代的单环烃基,可取代的多环烃基,可取代的单环杂环基或可取代的多环杂环基,R.sup.2和R.sup.7互相独立,分别是可取代的烷基,可取代的烷氧基,可取代的苯基或可取代的苯氧基,R.sup.3,R.sup.8和R.sup.10互相独立,分别是可取代的烷基,可取代的烯基,可取代的炔基,可取代的环烷基,可取代的苯基或可取代的苄基,R.sup.4,R.sup.5,R.sup.11和R.sup.12互相独立,分别是可取代的烷基,W.sup.1,W.sup.2,W.sup.3和W.sup.4互相独立,分别是氧原子或硫原子,m为0或1,但排除其中一个X和Y是--COCF.sub.2X.sup.1,其中X.sup.1是氢原子,卤素原子,烷基或卤代烷基,另一个是--COCF.sub.2X.sup.2,其中X.sup.2是氢原子,卤素原子,烷基,卤代烷基或烷基羰基,或--COOX.sup.3,其中X.sup.3是可取代的烷基或可取代的苯基的组合。
  • Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them
    申请人:ISHIHARA SANGYO KAISHA, LTD.
    公开号:EP0465913B1
    公开(公告)日:1997-09-10
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-